Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-26-000081
Filing Date
2026-08-05
Accepted
2026-08-05 14:40:40
Documents
66
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20260630.htm   iXBRL 10-Q 1271760
2 EX-10.1 lly-06302026x10qxexhibit101.htm EX-10.1 131916
3 EX-31.1 lly-06302026x10qxexhibit311.htm EX-31.1 10316
4 EX-31.2 lly-06302026x10qxexhibit312.htm EX-31.2 10347
5 EX-32 lly-06302026x10qxexhibit32.htm EX-32 6386
  Complete submission text file 0000059478-26-000081.txt   7585419

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20260630.xsd EX-101.SCH 37680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20260630_cal.xml EX-101.CAL 52950
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20260630_def.xml EX-101.DEF 199585
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20260630_lab.xml EX-101.LAB 510280
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20260630_pre.xml EX-101.PRE 357136
70 EXTRACTED XBRL INSTANCE DOCUMENT lly-20260630_htm.xml XML 1483869
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 261242780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)